Cheol-min Park

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

L. Lam, C. Tse, Cheol‐Min Park, 2013, Nature Medicine.

Selective binding of bryostatin analogues to the cysteine rich domains of protein kinase C isozymes.

H. Ohigashi, K. Irie, P. Wender, 1999, Bioorganic & medicinal chemistry letters.

N-aryl-benzimidazolones as novel small molecule HSP90 inhibitors.

Jun Chen, Saul H Rosenberg, Xiaohong Song, 2010, Bioorganic & medicinal chemistry letters.

Synthesis of the First Members of a New Class of Biologically Active Bryostatin Analogues

Makoto Shiozaki, P. Wender, M. Koehler, 1998 .